Anti-CD20 / TNFR1 bispecific and fusion antibodies for improving treatment of B cell Non-Hodgkin’s lymphoma

8 228

Cited 0 times in

DC Field	Value	Language
dc.contributor.author	김정렬	-
dc.date.accessioned	2022-08-23T01:50:01Z	-
dc.date.available	2022-08-23T01:50:01Z	-
dc.date.issued	2022-02	-
dc.identifier.uri	https://ir.ymlib.yonsei.ac.kr/handle/22282913/189614	-
dc.description.statementOfResponsibility	prohibition	-
dc.format	application/pdf	-
dc.publisher	Graduate School, Yonsei University	-
dc.rights	CC BY-NC-ND 2.0 KR	-
dc.title	Anti-CD20 / TNFR1 bispecific and fusion antibodies for improving treatment of B cell Non-Hodgkin’s lymphoma	-
dc.title.alternative	B세포 비호치킨 림프종의 치료를 높이는 항 CD20 / TNFR1이중항체 및 융합 항체의 개발과 적용	-
dc.type	Thesis	-
dc.contributor.college	College of Medicine (의과대학)	-
dc.contributor.department	Others (기타)	-
dc.description.degree	석사	-
dc.contributor.alternativeName	Kim, Jeong Ryeol	-
dc.type.local	Thesis	-

Appears in Collections:: 1. College of Medicine (의과대학) > Others (기타) > 2. Thesis

Show simple item record Find it @ YMLIB

YUHSpace: Anti-CD20 / TNFR1 bispecific and fusion antibodies for improving treatment of B cell Non-Hodgkin’s lymphoma